[{"address1": "1800 Sierra Point Parkway", "address2": "Suite 200", "city": "Brisbane", "state": "CA", "zip": "94005", "country": "United States", "phone": "650 484 0899", "website": "https://dayonebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.", "fullTimeEmployees": 181, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jeremy  Bender M.B.A., Ph.D.", "age": 53, "title": "CEO, President & Director", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 1195600, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Stubenrauch Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jaa  Roberson", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Davy  Chiodin Ph.D., Pharm.D.", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lauren  Merendino M.B.A.", "age": 48, "title": "Chief Commercial Officer", "yearBorn": 1976, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Elly  Barry M.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 5, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.76, "open": 6.69, "dayLow": 6.63, "dayHigh": 6.88, "regularMarketPreviousClose": 6.76, "regularMarketOpen": 6.69, "regularMarketDayLow": 6.63, "regularMarketDayHigh": 6.88, "payoutRatio": 0.0, "beta": -1.247, "forwardPE": -6.107143, "volume": 1174400, "regularMarketVolume": 1174400, "averageVolume": 1155500, "averageVolume10days": 1249090, "averageDailyVolume10Day": 1249090, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 693261376, "fiftyTwoWeekLow": 6.41, "fiftyTwoWeekHigh": 18.07, "priceToSalesTrailing12Months": 5.2855754, "fiftyDayAverage": 9.1263, "twoHundredDayAverage": 12.649125, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 164146896, "profitMargins": -0.72808, "floatShares": 71972855, "sharesOutstanding": 101354000, "sharesShort": 17481507, "sharesShortPriorMonth": 18177016, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.1725, "heldPercentInsiders": 0.16965, "heldPercentInstitutions": 0.94512004, "shortRatio": 12.56, "shortPercentOfFloat": 0.20809999, "impliedSharesOutstanding": 101355000, "bookValue": 4.972, "priceToBook": 1.3757039, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -95496000, "trailingEps": -1.02, "forwardEps": -1.12, "enterpriseToRevenue": 1.251, "enterpriseToEbitda": -0.779, "52WeekChange": -0.5552666, "SandP52WeekChange": 0.05430484, "quoteType": "EQUITY", "currentPrice": 6.84, "targetHighPrice": 36.0, "targetLowPrice": 21.0, "targetMeanPrice": 30.75, "targetMedianPrice": 32.0, "recommendationMean": 1.66667, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 531720000, "totalCashPerShare": 5.246, "ebitda": -210708000, "totalDebt": 2602000, "quickRatio": 7.428, "currentRatio": 7.656, "totalRevenue": 131161000, "debtToEquity": 0.518, "revenuePerShare": 1.407, "returnOnAssets": -0.27673, "returnOnEquity": -0.22488001, "grossProfits": 125882000, "freeCashflow": -133987752, "operatingCashflow": -78113000, "grossMargins": 0.95975, "ebitdaMargins": -1.60648, "operatingMargins": -2.23678, "financialCurrency": "USD", "symbol": "DAWN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1744920635, "regularMarketTime": 1744920001, "exchange": "NMS", "messageBoardId": "finmb_704589075", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1622122200000, "postMarketChangePercent": -0.292397, "postMarketPrice": 6.82, "postMarketChange": -0.02, "regularMarketChange": 0.07999992, "regularMarketDayRange": "6.63 - 6.88", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1155500, "fiftyTwoWeekLowChange": 0.4300003, "fiftyTwoWeekLowChangePercent": 0.06708273, "fiftyTwoWeekRange": "6.41 - 18.07", "fiftyTwoWeekHighChange": -11.23, "fiftyTwoWeekHighChangePercent": -0.62147206, "fiftyTwoWeekChangePercent": -55.52666, "epsTrailingTwelveMonths": -1.02, "epsForward": -1.12, "epsCurrentYear": -1.54679, "priceEpsCurrentYear": -4.4220614, "shortName": "Day One Biopharmaceuticals, Inc", "longName": "Day One Biopharmaceuticals, Inc.", "fiftyDayAverageChange": -2.2862997, "fiftyDayAverageChangePercent": -0.2505177, "twoHundredDayAverageChange": -5.809125, "twoHundredDayAverageChangePercent": -0.45925114, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-05-27", "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "regularMarketChangePercent": 1.1834308, "regularMarketPrice": 6.84, "marketState": "CLOSED", "displayName": "Day One Biopharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-04-19"}]